CRESUD S.A.C.I.F. y A. announces its results for the first quarter of Fiscal Year 2024 ended September 30, 2023
BUENOS AIRES, Argentina, Nov. 9, 2023 /PRNewswire/ -- Cresud S.A.C.I.F. y A. (NASDAQ: CRESY, BYMA: CRES), leading Argentine agricultural company, announces today its results for the first quarter of FY 2024 ended September 30, 2023.
HIGHLIGHTS
The net result for the first quarter of fiscal year 2024 recorded a gain of ARS 78,969 million compared to ARS 12,471 million in the same period of 2023, mainly due to the gain from changes in the fair value of IRSA's investment properties. The gain attributable to the controlling shareholder was ARS 40,780 million, compared to ARS 8,271 million in the same period of 2023.
The adjusted EBITDA for the period reached ARS 14,340 million, 39.1% lower than the same period in 2023. The adjusted EBITDA of the agricultural segments was ARS 5,069 million.
The 2024 campaign is being developed with better weather conditions in the region, mainly in Argentina, and correction of international commodity prices and costs. We hope to plant approximately 289,000 hectares, 2% more than in the 2023 campaign.
After the end of the quarter, we sold a fraction of 4,262 hectares of reserve with productive potential of "Los Pozos" farm, in the province of Salta, Argentina, for USD 2.3 million.
On October 5, 2023, the Shareholders' Meeting approved the distribution of a cash dividend of ARS 22,000 million and in kind through the delivery of 22.1 million IRSA shares, as well as approved the distribution of own treasury shares, representing approximately 1% of the stock capital.
Financial Highlights
(In millions of Argentine Pesos)
3M FY 2024 ended September 30, 2023
Income Statement
09/30/2023
09/30/2022
Agricultural Business Revenue
36,696
43,653
Agricultural Business Gross Profit
4,003
5,456
Urban Properties Revenues
25,302
22,194
Urban Properties Gross Profit
20,960
17,784
Consolidated Gross Profit
24,856
22,846
Consolidated results from Operations
116,430
(1,614)
Profit for the Period
78,969
12,471
Attributable to:
Cresud's Shareholders
40,780
8,271
Non-Controlling interest
38,189
4,200
EPS (Basic)
68.91
13.96
EPS (Diluted)
58.88
11.95
Balance Sheet
09/30/2023
06/30/2023
Current Assets
315,001
289,782
Non-Current Assets
1,241,538
1,151,935
Total Assets
1,556,539
1,441,717
Current Liabilities
286,437
268,929
Non-Current Liabilities
548,952
525,468
Total Liabilities
835,389
794,397
Non-Controlling Interest
402,708
366,854
Shareholders' Equity
721,150
647,320
The Company's market capitalization as of September 30, 2023, was approximately USD 397 million. (59,345,404 ADS with a price per ADS of USD 6.69)
Cresud, leading Argentinean agricultural company with a growing presence in Latin American countries, cordially invites you to participate in its first quarter of the FY 2024 Results Conference Call on Thursday, November 9, 2023, at 10:00 AM Eastern Time / 12:00 PM BA Time.
TSX VENTURE COMPANIES
BULLETIN V2024-2028
BLACKWOLF COPPER AND GOLD LTD. ("BWCG")BULLETIN TYPE: Plan of Arrangement, Shares for Bonuses, Property-Asset or Share Purchase Agreement, DelistBULLETIN DATE: July 3, 2024TSX Venture Tier 2 Company
Plan of...
Intermap Technologies ("Intermap" or the "Company"), a global leader in 3D geospatial products and intelligence solutions, announces a new financing. The Company is offering up to a maximum of 4,300,000 Class "A" common shares of the Company...
Daiso, the renowned global retail chain offering a wide range of affordable and unique products, is thrilled to announce the grand opening of its first Oregon store at Sunset Esplanade in Hillsboro, Oregon on July 20th. "We are thrilled to open our...
Daiso, the renowned global retail chain offering a wide range of affordable and unique products, is thrilled to announce the grand opening at Bay Colony Town Center in League City, Texas on July 13th. "We are thrilled to open our store at Bay Colony...
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies for hematological malignancies, announced today that on July 2, 2024, in relation to...
BOXABL, the innovative housing startup known for its foldable Casita homes and building technology, has announced this week that investors have indicated they want to invest over $10MM in the current stock offering. BOXABL previously SOLD OUT the Reg...